Recent News

AffyImmune Therapeutics Announces Hiring of Matt Britz as Senior Vice President of Business Development

NATICK, Mass., June 21, 2021 /PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR-T cells against solid cancers, announced today the addition of Matt Britz to its management team as its Senior Vice President of Business Development. "Matt brings deep industry experience, a [...]